{"log_id": 9163423230875345664, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.000837, "average": 0.986366, "min": 0.853981}, "location": {"width": 1711, "top": 287, "height": 74, "left": 204}, "words": "建议暂停用药,同时需监测血清转氨酶及总胆红素直至其水平明显下降后可恢复用药:如恢复"}, {"probability": {"variance": 0.00519, "average": 0.97687, "min": 0.551475}, "location": {"width": 1705, "top": 359, "height": 71, "left": 207}, "words": "用药后再次出现34级不良反应,可下调一个剂量后继续用药(参见【用法用量】),如不良"}, {"probability": {"variance": 1.6e-05, "average": 0.997039, "min": 0.988795}, "location": {"width": 419, "top": 431, "height": 51, "left": 207}, "words": "反应仍持续,建议停药"}, {"probability": {"variance": 0.000163, "average": 0.988747, "min": 0.96359}, "location": {"width": 209, "top": 552, "height": 46, "left": 247}, "words": "般注意事项"}, {"probability": {"variance": 0.012083, "average": 0.947114, "min": 0.559579}, "location": {"width": 1619, "top": 609, "height": 71, "left": 287}, "words": "血压升高:血压升高是 VEGER抑测剂类抗肿瘤药物最常见的不良反应之一。临床研究中"}, {"probability": {"variance": 0.0033, "average": 0.982491, "min": 0.633065}, "location": {"width": 1702, "top": 673, "height": 69, "left": 204}, "words": "察到服用阿柏替尼可引起血压升高,一般为轻到中度,多在服药后2周左右出现,常规的降"}, {"probability": {"variance": 0.000486, "average": 0.991524, "min": 0.887128}, "location": {"width": 1702, "top": 736, "height": 69, "left": 204}, "words": "压药物一般可以控制。服药期间应常规监测血压的变化,如有需要应在专科医师指导下进行降"}, {"probability": {"variance": 0.001544, "average": 0.98939, "min": 0.747399}, "location": {"width": 1702, "top": 799, "height": 69, "left": 204}, "words": "压治疗或调整本品剂量。如发生34级血压升高,建议暂停用药;如恢复用药后再次出现34"}, {"probability": {"variance": 0.001441, "average": 0.980526, "min": 0.807516}, "location": {"width": 1702, "top": 860, "height": 74, "left": 201}, "words": "级血压升高,可下调一个剂量后继续用药(参见【用法用量】),如不良反应仍持续,建议停"}, {"probability": {"variance": 0.002277, "average": 0.975768, "min": 0.793491}, "location": {"width": 926, "top": 926, "height": 60, "left": 201}, "words": "药。对于高血压危象的患者,发生期间应停用本品"}, {"probability": {"variance": 0.011188, "average": 0.970689, "min": 0.428946}, "location": {"width": 1619, "top": 986, "height": 71, "left": 284}, "words": "蛋白尿:蛋白尿是 VEGFR排制剂类抗肿瘤药物最常见的不良反应之一临床研究中观察"}, {"probability": {"variance": 0.005919, "average": 0.963297, "min": 0.604116}, "location": {"width": 1699, "top": 1049, "height": 69, "left": 201}, "words": "到服用阿帕替尼可引起蛋白尿,当用于肾功能不全思者时应慎和密切监测。建议患者定期检"}, {"probability": {"variance": 0.00559, "average": 0.978514, "min": 0.545974}, "location": {"width": 1682, "top": 1110, "height": 69, "left": 201}, "words": "查尿常规,在用药的最初两个月内应定期例如每2周检查1次尿常规:之后每4周检查1次"}, {"probability": {"variance": 0.012702, "average": 0.962082, "min": 0.382507}, "location": {"width": 1699, "top": 1173, "height": 69, "left": 198}, "words": "发生蛋白尿时诸及时就医。如发生≥2级的蛋白尿,建议暂停用药;如恢复用药后再次出现"}, {"probability": {"variance": 0.003856, "average": 0.975028, "min": 0.638162}, "location": {"width": 1702, "top": 1236, "height": 60, "left": 195}, "words": "2级的蛋白尿,可下调一个剂量后继续用药(参见【用法用量】),如不良反应仍持续,建议"}, {"probability": {"variance": 0, "average": 0.99939, "min": 0.998981}, "location": {"width": 89, "top": 1297, "height": 46, "left": 198}, "words": "停药"}, {"probability": {"variance": 0.001562, "average": 0.972997, "min": 0.797357}, "location": {"width": 1613, "top": 1357, "height": 69, "left": 284}, "words": "皮肤毒性手足综合征(手、足底红肿疼痛或指端红斑)是服用本品后最常见的皮肤不"}, {"probability": {"variance": 0.002925, "average": 0.973956, "min": 0.693433}, "location": {"width": 1697, "top": 1418, "height": 69, "left": 204}, "words": "良反应,通常为轻中度(1-2级)1级手足综合征定义为出现下列任一现象:手和或足的麻"}, {"probability": {"variance": 0.004336, "average": 0.977465, "min": 0.581318}, "location": {"width": 1697, "top": 1481, "height": 63, "left": 198}, "words": "木、感觉迟钝感觉异常、麻朝感、红斑和或不影响正常活动的不适;2级定义为手和或足的"}, {"probability": {"variance": 0.023537, "average": 0.93964, "min": 0.433558}, "location": {"width": 1665, "top": 1541, "height": 66, "left": 195}, "words": "疼痛性红斑和肿胀和减影响患者日工作的不适:3级定义为手和/或足的湿性脱屑、溃疡"}, {"probability": {"variance": 0.008436, "average": 0.960621, "min": 0.54714}, "location": {"width": 1662, "top": 1602, "height": 69, "left": 195}, "words": "水疱或严重的疼痛和或使思者不能工作或进行日常工作的严重不适。如果发生手足综合征"}, {"probability": {"variance": 0.013855, "average": 0.958376, "min": 0.385356}, "location": {"width": 1699, "top": 1665, "height": 63, "left": 201}, "words": "可在医师指导下采取一些必要的对症支持治疗:包括:加强皮肤护理,保持皮肤清避免继"}, {"probability": {"variance": 0.014239, "average": 0.932923, "min": 0.464448}, "location": {"width": 1699, "top": 1725, "height": 66, "left": 195}, "words": "发感染:避免压力或摩擦:使用润肤霜或润滑剂,局部使用含尿素和皮类固醇成分的液或"}, {"probability": {"variance": 0.005777, "average": 0.971289, "min": 0.550254}, "location": {"width": 1702, "top": 1789, "height": 63, "left": 195}, "words": "润滑剂:必要时局部使用抗真菌或抗生素治疗。如连续出现3次≥2级的手足综合征,且有加"}, {"probability": {"variance": 0.009148, "average": 0.966823, "min": 0.487438}, "location": {"width": 1702, "top": 1846, "height": 66, "left": 195}, "words": "量趋势的,建议暂停用药;如恢复用药后再次出现≥2级的手足综合征可不调一个剂量后继"}, {"probability": {"variance": 0.017981, "average": 0.938707, "min": 0.42186}, "location": {"width": 1130, "top": 1909, "height": 60, "left": 195}, "words": "续用药(参见【用法用量】),如不良反应仍持续建议停药"}, {"probability": {"variance": 0.007867, "average": 0.965427, "min": 0.492102}, "location": {"width": 1619, "top": 1976, "height": 54, "left": 276}, "words": "腹泻:腹患者服用本品可能会影响本品的吸收,故应积极治疗导致腹浅的疾病,好转后"}, {"probability": {"variance": 5.9e-05, "average": 0.993393, "min": 0.977863}, "location": {"width": 460, "top": 2033, "height": 51, "left": 198}, "words": "可在医师指导下服用本品"}, {"probability": {"variance": 0.0231, "average": 0.93721, "min": 0.382286}, "location": {"width": 1613, "top": 2105, "height": 63, "left": 279}, "words": "眼用本品期间如发生3/4级腹,建议暂停用药;如恢复用药后再次出现34级腹泻,可"}, {"probability": {"variance": 0.004695, "average": 0.970136, "min": 0.664206}, "location": {"width": 1464, "top": 2174, "height": 57, "left": 201}, "words": "下调一个剂量后继续用药(梦见【用法用量1),如不良反应仍持续;建议停药"}, {"probability": {"variance": 0.005697, "average": 0.958266, "min": 0.692469}, "location": {"width": 1622, "top": 2243, "height": 63, "left": 276}, "words": "伤口愈合并发症:未进行服用阿帕替尼对伤口愈合影响的专门研究。在阿帕替尼临床研究"}, {"probability": {"variance": 0.002191, "average": 0.983053, "min": 0.797183}, "location": {"width": 1697, "top": 2315, "height": 54, "left": 195}, "words": "中除了4周内进行过大手术伤口未愈合的患者。鉴于手术后患者何时再服用阿帕替尼的经验"}, {"probability": {"variance": 0.010647, "average": 0.967232, "min": 0.474771}, "location": {"width": 1067, "top": 2384, "height": 51, "left": 195}, "words": "有限,建议手术前及手术后的30天内,暂时停止服用本品"}, {"probability": {"variance": 0.013507, "average": 0.962066, "min": 0.430085}, "location": {"width": 1628, "top": 2476, "height": 57, "left": 276}, "words": "对驾驶及换纵机器能力的影响在本品治疗期间,可能会出现乏力的症状,建议患者在驾"}, {"probability": {"variance": 0.003391, "average": 0.97623, "min": 0.784878}, "location": {"width": 509, "top": 2539, "height": 48, "left": 192}, "words": "驶或操纵机器时应予以注意"}, {"probability": {"variance": 0.038825, "average": 0.877127, "min": 0.535923}, "location": {"width": 169, "top": 2603, "height": 46, "left": 279}, "words": "患者须知"}], "language": -1}